SYNLAB - About the company
SYNLAB is a public company based in Munich (Germany), founded in 1998. It operates as a Provider of medical diagnosis and clinical laboratory analysis services. SYNLAB has raised an undisclosed amount in funding. The company has 81 active competitors, including 8 funded and 14 that have exited. Its top competitors include companies like Natera, Beikang Medical and Progenity.
Company Details
SYNLAB is a leading provider of medical diagnosis and clinical laboratory analysis services in Europe. They offer advanced laboratory services in various diagnostic categories for the benefit of their customers. SYNLAB has a global network and a team of over 28,000 employees, including medical experts, who contribute to their success.
- Website
- Social
- Email ID
- @synlab.com
- Phone Number
- +49
- Part Of
- cinven.com
Legal entities associated with SYNLAB
SYNLAB is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
---|---|---|---|---|
CIN: HRB 272321 Germany, Active | Dec 31, 1997 | - | 28693 (as on Dec 31, 2022) | - |
Get your free copy of SYNLAB's company profile
SYNLAB's funding and investors
SYNLAB has raised funding over 4 rounds. Its first funding round was on Sep 01, 2009. Its latest funding round was a Grant (prize money) round on Dec 31, 2016 for $1.8M. 1 investor participated in its latest round, which include SVG Capital, BC Partners, Novo Holdings and Idinvest Partners.
SYNLAB has 8 institutional investors including , BC Partners and Novo Holdings.
Here is the list of recent funding rounds of SYNLAB:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
---|---|---|---|---|---|
Dec 31, 2016 | $1.8M | Grant (prize money) | 5589541 | 4562426 | |
Sep 01, 2016 | Undisclosed | Grant (prize money) | 8817758 | 8055864 | |
Feb 03, 2016 | Undisclosed | Series A | 8153816 | 1354698 |
View details of SYNLAB's funding rounds and investors
SYNLAB's founders and board of directors
SYNLAB's employee count trend
SYNLAB has 28,693 employees as of Dec 22. The total employee count is 6.0% lower than what it was in Dec 21. Here is SYNLAB's employee count trend over the years:Access ÃØÃÜÑо¿Ëù on any website
Our Google Chrome extension lets you view company details while browsing their websites
SYNLAB's Competitors and alternates
Top competitors of SYNLAB include Natera, Beikang Medical and Progenity. Here is the list of Top 10 competitors of SYNLAB, ranked by ÃØÃÜÑо¿Ëù score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
---|---|---|---|---|---|
1st | Natera 2004, Redwood City (United States), Public | Developer of cell-free DNA testing for oncology, women’s health, and organ health | $152M | Sofinnova Investments, Foresite CapitalÌý&²¹³¾±è;Ìý | 73/100 |
2nd | ![]() 1998, Munich (Germany), Public | Provider of medical diagnosis and clinical laboratory analysis services | - | SVG Capital, BC PartnersÌý&²¹³¾±è;Ìý | 56/100 |
3rd | Beikang Medical 2010, Suzhou (China), Public | Developer of NGS-based diagnostic solutions for neonatal | $36.5M | Genesis Capital, Broad Vision FundsÌý&²¹³¾±è;Ìý | 54/100 |
4th | ![]() Progenity 2011, San Diego (United States), Public | Provider of non invasive prenatal genomic testing | $217M | Athyrium Capital Management, TRITON FUNDSÌý&²¹³¾±è;Ìý | 54/100 |
5th | Provider of a non-invasive prenatal screening test for genetic syndromes | $9.8M | eHealth VenturesÌý&²¹³¾±è;Ìý | 50/100 | |
6th | Sequenom 1994, San Diego (United States), Acquired | Provider of noninvasive prenatal testing using circulating cell-free fetal nucleic acids | - | SR One, Star VenturesÌý&²¹³¾±è;Ìý | 45/100 |
7th | Berry Genomics 2010, Beijing (China), Public | Provider of genetic testing products and tests | $16M | Legend Star, Legend CapitalÌý&²¹³¾±è;Ìý | 45/100 |
8th | ![]() Nonacus 2015, Birmingham (United Kingdom), Unfunded | Provider of technology and services for genomic healthcare | - | - | 44/100 |
9th | Gennet 1996, Prague (Czech Republic), Acquired | Provider of genetics and IVF services | - | - | 42/100 |
10th | ![]() Yourgene Health 2000, Manchester (United Kingdom), Public | Provider of non-invasive prenatal genetic tests and genomic services | - | Seneca EIS Portfolio Fund, Calculus CapitalÌý&²¹³¾±è;Ìý | 42/100 |
Looking for more details on SYNLAB's competitors? Click to see the top ones
SYNLAB's Investments and acquisitions
SYNLAB has not made any investments yet. SYNLAB has made 11 acquisitions. Here is the list of latest three $acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
---|---|---|---|---|
May 31, 2023 | Acquisition | 2015 | Sant Antimo, | |
Aug 08, 2022 | Acquisition | ![]() | 1978 | Belluno, |
Aug 08, 2022 | Acquisition | ![]() | 2015 | Belluno, |
See all acquisitions by SYNLAB
News related to SYNLAB
Media has covered SYNLAB for a total of 9 events in the last 1 year, 1 of them has been about company updates.
•
•
•
•
•
•
•
•
Global Legal Chronicle•Sep 06, 2024•, SYNLAB, ,
•
Are you a Founder ?
FAQ's about SYNLAB
Explore our recently published companies
- dAIgnostiX - Bengaluru based, 2018 founded, Unfunded company
- Globe Teleservices - Singapore based, 2012 founded, Unfunded company
- ActionPoint - Bucharest based, 2021 founded, Public company